Rudolf Stadler

10.8k total citations · 1 hit paper
188 papers, 4.1k citations indexed

About

Rudolf Stadler is a scholar working on Dermatology, Oncology and Epidemiology. According to data from OpenAlex, Rudolf Stadler has authored 188 papers receiving a total of 4.1k indexed citations (citations by other indexed papers that have themselves been cited), including 113 papers in Dermatology, 67 papers in Oncology and 55 papers in Epidemiology. Recurrent topics in Rudolf Stadler's work include Cutaneous lymphoproliferative disorders research (89 papers), Lymphoma Diagnosis and Treatment (43 papers) and Cutaneous Melanoma Detection and Management (35 papers). Rudolf Stadler is often cited by papers focused on Cutaneous lymphoproliferative disorders research (89 papers), Lymphoma Diagnosis and Treatment (43 papers) and Cutaneous Melanoma Detection and Management (35 papers). Rudolf Stadler collaborates with scholars based in Germany, United States and Switzerland. Rudolf Stadler's co-authors include Constantin E. Orfanos, Claus Garbe, Thomas A. Luger, Reinhard Dummer, Jens Ulrich, Michael Detmar, Chalid Assaf, Robert Knobler, Bernhard Korge and Dietmar Mischke and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Analytical Chemistry.

In The Last Decade

Rudolf Stadler

171 papers receiving 4.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Complete lymph node dissection versus no dissection in patients with sentinel lymph node biopsy positive melanoma (DeCOG-SLT): a multicentre, randomised, phase 3 trial

2016 405 citations Rudolf Stadler, Claus Garbe et al. profile →

Peers

Countries citing papers authored by Rudolf Stadler

Since Specialization

Citations

This map shows the geographic impact of Rudolf Stadler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rudolf Stadler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rudolf Stadler more than expected).

Fields of papers citing papers by Rudolf Stadler

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rudolf Stadler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rudolf Stadler. The network helps show where Rudolf Stadler may publish in the future.

Co-authorship network of co-authors of Rudolf Stadler

This figure shows the co-authorship network connecting the top 25 collaborators of Rudolf Stadler. A scholar is included among the top collaborators of Rudolf Stadler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rudolf Stadler. Rudolf Stadler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Low‐dose total skin electron beam therapy in erythrodermic mycosis fungoides and Sézary syndrome: Results From the Prospective S‐MISR Study 2025 ·JDDG Journal der Deutschen Dermatologischen Gesellschaft ·Khaled Elsayad, Christian Kandler, (unknown), (unknown), (unknown), Gábor Dobos, Elisabeth Livingstone, Susanne Melchers, Johannes Kleemann, Julia Hyun, Claudia Pföhler, (unknown), Jan P. Nicolay, Rudolf Stadler, Hans Theodor Eich	0
2	Pegylated Interferon Combined With Low-Dose Total Skin Electron Beam Therapy for Advanced Stage Mycosis Fungoides: Two Case Reports and Literature Review 2024 ·Advances in Radiation Oncology ·Khaled Elsayad, Rudolf Stadler, Hans Theodor Eich	0
3	Associations between tobacco smoking status and patch test results—A cross‐sectional pilot study from the Information Network of Departments of Dermatology (IVDK) 2024 ·Contact Dermatitis ·Sonja Molin, Richard Brans, Andrea Bauer, Detlef Becker, Burkhard Kreft, Vera Mahler, Christoph Skudlik, Rudolf Stadler, Christiane Szliska, Elke Weißhaar, Johannes Geier	0
4	A-139 B2 involvement as a surrogate marker for a rapid and sustained response to treatment with mogamulizumab in mycosis fungoides and Sézary syndrome 2024 ·European Journal of Cancer ·Rudolf Stadler, (unknown), (unknown), (unknown), (unknown), Ralf Gutzmer	1
5	Nanopore Sequencing for T-Cell Receptor Rearrangement Analysis in Cutaneous T-Cell Lymphoma 2024 ·Cancers ·(unknown), (unknown), Christian Rückert, Tobias Busche, (unknown), (unknown), Ralf Gutzmer, Jörn Kalinowski, Rudolf Stadler	3
6	Potential Pathogenic Impact of Cow’s Milk Consumption and Bovine Milk-Derived Exosomal MicroRNAs in Diffuse Large B-Cell Lymphoma 2023 ·International Journal of Molecular Sciences ·Bodo C. Melnik, Rudolf Stadler, Ralf Weiskirchen, Claus Leitzmann, Gerd Schmitz	12
7	Diagnostic and prognostic classification of atypical spitzoid tumours based on histology and genomic aberrations: A prospective cohort study with long-term follow-up 2022 ·European Journal of Cancer ·Maximilian Gassenmaier, (unknown), Laura Held, Gisela Metzler, Amir S. Yazdi, Ines B. Brecht, Dominik T. Schneider, Rudolf Stadler, Claus Garbe, Jürgen Bauer	5
8	Significant association of cutaneous adverse events with hydroxyurea: results from a prospective non-interventional study in BCR-ABL1-negative myeloproliferative neoplasms (MPN) - on behalf of the German Study Group-MPN 2020 ·Leukemia ·Frank Stegelmann, Kai Wille, (unknown), Christiane Fuchs, Stefanie Schauer, Parvis Sadjadian, Tatjana Becker, (unknown), Hartmut Döhner, Rudolf Stadler, (unknown), Konstanze Döhner, Martin Grießhammer	9
9	Management of primary cutaneous lymphoma patients during COVID‐19 pandemic: EORTC CLTF guidelines 2020 ·Journal of the European Academy of Dermatology and Venereology ·Evangelia Papadavid, Julia Scarisbrick, Pablo L. Ortiz‐Romero, (unknown), Maarten H. Vermeer, Robert Knobler, Rudolf Stadler, M. Bagot	10
10	Maintenance therapy in patients with mycosis fungoides or Sézary syndrome: A neglected topic 2020 ·European Journal of Cancer ·Rudolf Stadler, Julia Scarisbrick	17
11	Innovative Treatment Concepts for Cutaneous T-Cell Lymphoma Based on Microenvironment Modulation 2017 ·Oncology Research and Treatment ·(unknown), Max Schlaak, Rudolf Stadler, Sebastian Theurich, Michael von Bergwelt‐Baildon	9
12	Haut auf der Grenze zwischen Innen und Außen 2014 ·JDDG Journal der Deutschen Dermatologischen Gesellschaft ·Rudolf Stadler, Roland Kaufmann, Thomas A. Luger	0
13	Prospective International Multicenter Phase II Trial of Intravenous Pegylated Liposomal Doxorubicin Monochemotherapy in Patients With Stage IIB, IVA, or IVB Advanced Mycosis Fungoides: Final Results From EORTC 21012 2012 ·Journal of Clinical Oncology ·Reinhard Dummer, Pietro Quaglino, Jürgen C. Becker, Baktiar Hasan, Matthias Karrasch, Sean Whittaker, Stephen Morris, Michael Weichenthal, Rudolf Stadler, M. Bagot, Antonio Cozzio, Maria Grazia Bernengo, Robert Knobler	70
14	Skin cancer screening in Germany – perception by the public 2011 ·JDDG Journal der Deutschen Dermatologischen Gesellschaft ·Matthias Augustin, Rudolf Stadler, Michael Reusch, Ines Schäfer, Thomas Kornek, Thomas A. Luger	39
15	Optimal combination with PUVA: rationale and clinical trial update. 2007 ·PubMed ·Rudolf Stadler	9
16	Cutaneous lymphomas in Germany: an analysis of the Central Cutaneous Lymphoma Registry of the German Society of Dermatology (DDG) 2007 ·JDDG Journal der Deutschen Dermatologischen Gesellschaft ·Chalid Assaf, Sylke Gellrich, Matthias Steinhoff, Dorothée Nashan, (unknown), Edgar Dippel, Esther A. Coors, (unknown), (unknown), (unknown), (unknown), André Koch, Claus‐Detlev Klemke, Rudolf Stadler, Wolfram Sterry	68
17	Long-term survival benefit after adjuvant treatment of cutaneous melanoma with dacarbazine and low dose natural interferon alpha: A controlled, randomised multicentre trial 2006 ·Acta Oncologica ·Rudolf Stadler, (unknown), Thomas Bieber, Ulrike A. Köhler, R Linse, (unknown), Roland Schubert, (unknown), (unknown), Matthias Volkenandt, Harald Gollnick, (unknown), Fredrik B. Thorén, Örjan Strannegård	23
18	[Local recurrence and metastasis of thin malignant melanomas (less than or equal to 1mm)]. 1989 ·PubMed ·Claus Garbe, Rudolf Stadler, C.E. Orfanos	4
19	Dermatology in five continents : proceedings of the XVII. World Congress of Dermatology, Berlin, May 24-29, 1987 1988 ·Springer eBooks ·Constantin E. Orfanos, Rudolf Stadler, (unknown)	2
20	Effect of a new retinoid, arotinoid (Ro 13-6298), on in vitro keratinocyte proliferation and differentiation 1984 ·Acta Dermato Venereologica ·Rudolf Stadler, (unknown), (unknown), (unknown)	11

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact